BIOT
Biotech Acquisition Company Class A Ordinary Shares
BIOT
BIOT
Delisted
BIOT was delisted on the 2nd of February, 2023.
69 hedge funds and large institutions have $226M invested in Biotech Acquisition Company Class A Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
+2
Holders Change %
+2.99%
% of All Funds
1.19%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
15
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GCL
1
Glazer Capital LLC
New York
|
$22.7M |
| 2 |
2
HSBC Holdings
London,
United Kingdom
|
$6.34M |
| 3 |
MSU
3
Mizuho Securities USA
New York
|
$4.38M |
| 4 |
4
Millennium Management
New York
|
$7.01M |
| 5 |
WRBC
5
W.R. Berkley Corp
Greenwich,
Connecticut
|
$2.86M |
